S G Kornstein

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. ncbi request reprint The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases
    Martin B Keller
    Brown University, Providence, Rhode Island 02906, USA
    Biol Psychiatry 62:1371-9. 2007
  2. ncbi request reprint Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression
    S G Kornstein
    Department of Psychiatry, Virginia Commonwealth University, Richmond, VA 23298, USA
    Psychol Med 35:683-92. 2005
  3. ncbi request reprint Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies
    Susan G Kornstein
    Virginia Commonwealth University School of Medicine, Richmond 23298 0710, USA
    J Clin Psychiatry 67:1624-32. 2006
  4. ncbi request reprint Gender differences in treatment response to sertraline versus imipramine in chronic depression
    S G Kornstein
    Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298 0710, USA
    Am J Psychiatry 157:1445-52. 2000
  5. ncbi request reprint Clinical features of treatment-resistant depression
    S G Kornstein
    Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0253, USA
    J Clin Psychiatry 62:18-25. 2001
  6. ncbi request reprint The evaluation and management of depression in women across the life span
    S G Kornstein
    Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0710, USA
    J Clin Psychiatry 62:11-7. 2001
  7. ncbi request reprint Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs
    Meir Steiner
    Department of Psychiatry and Behavioral Neurosciences, McMaster University, Women s Health Concerns Clinic, St Joseph s Hospital, Hamilton, Ontario, Canada
    J Womens Health (Larchmt) 15:57-69. 2006
  8. ncbi request reprint Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients
    Donna E Stewart
    University Health Network, University of Toronto, Ontario, Canada
    J Affect Disord 94:183-9. 2006
  9. ncbi request reprint Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials
    Susan G Kornstein
    Department of Psychiatry, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, USA
    J Clin Psychiatry 67:761-70. 2006
  10. ncbi request reprint Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study
    Susan G Kornstein
    Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, VA 23298 0710, USA
    CNS Spectr 11:28-34. 2006

Research Grants

  1. Symptom Onset Antidepressant Treatment for PMDD
    Susan Kornstein; Fiscal Year: 2009
  2. Symptom Onset Antidepressant Treatment for PMDD
    Susan Kornstein; Fiscal Year: 2007
  3. Symptom Onset Antidepressant Treatment for PMDD
    Susan G Kornstein; Fiscal Year: 2010

Detail Information

Publications34

  1. ncbi request reprint The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases
    Martin B Keller
    Brown University, Providence, Rhode Island 02906, USA
    Biol Psychiatry 62:1371-9. 2007
    ..We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment...
  2. ncbi request reprint Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression
    S G Kornstein
    Department of Psychiatry, Virginia Commonwealth University, Richmond, VA 23298, USA
    Psychol Med 35:683-92. 2005
    ..The NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study provides a unique opportunity to evaluate PME in depressed women seeking treatment in primary care or psychiatric settings...
  3. ncbi request reprint Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies
    Susan G Kornstein
    Virginia Commonwealth University School of Medicine, Richmond 23298 0710, USA
    J Clin Psychiatry 67:1624-32. 2006
    ....
  4. ncbi request reprint Gender differences in treatment response to sertraline versus imipramine in chronic depression
    S G Kornstein
    Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298 0710, USA
    Am J Psychiatry 157:1445-52. 2000
    ..The authors examined gender differences in treatment response to sertraline, a selective serotonin reuptake inhibitor (SSRI), and to imipramine, a tricyclic antidepressant, in chronic depression...
  5. ncbi request reprint Clinical features of treatment-resistant depression
    S G Kornstein
    Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0253, USA
    J Clin Psychiatry 62:18-25. 2001
    ..This article reviews the current literature regarding the clinical characteristics of treatment-resistant depression, with particular attention to the relevance of these factors for clinical decision making...
  6. ncbi request reprint The evaluation and management of depression in women across the life span
    S G Kornstein
    Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0710, USA
    J Clin Psychiatry 62:11-7. 2001
    ..This article will focus on special considerations in the evaluation and management of depression in women across the life span...
  7. ncbi request reprint Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs
    Meir Steiner
    Department of Psychiatry and Behavioral Neurosciences, McMaster University, Women s Health Concerns Clinic, St Joseph s Hospital, Hamilton, Ontario, Canada
    J Womens Health (Larchmt) 15:57-69. 2006
    ....
  8. ncbi request reprint Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients
    Donna E Stewart
    University Health Network, University of Toronto, Ontario, Canada
    J Affect Disord 94:183-9. 2006
    ..Pooled data from double-blind, placebo-controlled studies were utilized to assess the safety and tolerability of duloxetine in the treatment of major depressive disorder (MDD) in male and female patients...
  9. ncbi request reprint Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials
    Susan G Kornstein
    Department of Psychiatry, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, USA
    J Clin Psychiatry 67:761-70. 2006
    ..Pooled data from double-blind, placebo-controlled studies were utilized to compare the efficacy of duloxetine in the treatment of major depressive disorder (MDD) in male and female patients...
  10. ncbi request reprint Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study
    Susan G Kornstein
    Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, VA 23298 0710, USA
    CNS Spectr 11:28-34. 2006
    ....
  11. ncbi request reprint Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial
    Susan G Kornstein
    Department of Psychiatry, Virginia Commonwealth University, Richmond, USA
    J Clin Psychiatry 67:1767-75. 2006
    ..The current trial examined the efficacy of maintenance escitalopram treatment in preventing depression recurrence in patients who responded to acute SSRI therapy...
  12. ncbi request reprint Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions
    George I Papakostas
    Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Int Clin Psychopharmacol 22:226-9. 2007
    ..This finding could, however, not be replicated when improvement in anxious/somatic symptoms was defined as a continuous measure...
  13. ncbi request reprint Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status
    Anne T Harvey
    Via Christi Research, Inc, Wichita, Kan 67214, USA
    J Clin Psychiatry 68:951-8. 2007
    ....
  14. pmc Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression
    Elizabeth A Young
    Department of Psychiatry and Molecular and Behavioral Neurosciences Institute, University of Michigan, MBNI, 205 Zina Pitcher Place, Ann Arbor, MI 48109 0720, and Massachusetts General Hospital, Boston 02114, USA
    Psychoneuroendocrinology 32:843-53. 2007
    ....
  15. ncbi request reprint Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
    J Clin Psychiatry 68:1014-23. 2007
    ..To test the long-term efficacy and safety of venlafaxine extended-release (ER) in preventing recurrence in patients with major depression...
  16. ncbi request reprint The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases
    Martin B Keller
    Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
    J Clin Psychiatry 68:1246-56. 2007
    ..To report second-year results from the 2-year maintenance phase of a long-term study to evaluate the efficacy and safety of venlafaxine extended release (ER) in preventing recurrence of depression...
  17. ncbi request reprint A comparison of initial duloxetine dosing strategies in patients with major depressive disorder
    Virgil G Whitmyer
    Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, Ind, USA
    J Clin Psychiatry 68:1921-30. 2007
    ..To compare the effects of starting doses of duloxetine taken with or without food on tolerability and efficacy in patients with major depressive disorder (MDD)...
  18. doi request reprint Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study
    Susan G Kornstein
    Mood Disorders Institute, Institute for Women s Health, Department of Psychiatry, Virginia Commonwealth University, PO Box 980710, Richmond, VA 23298, USA
    Expert Rev Neurother 8:737-42. 2008
    ..The PREVENT study adds to current understanding regarding the benefits of long-term antidepressant therapy in preventing recurrence...
  19. ncbi request reprint Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, 3811 O Hara Street, Pittsburgh, PA 15213 2593, USA
    J Womens Health (Larchmt) 14:609-16. 2005
    ..To investigate whether differences in antidepressant efficacy are moderated by an interaction of age and gender...
  20. ncbi request reprint Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not
    Alan F Schatzberg
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5717, USA
    Arch Gen Psychiatry 62:513-20. 2005
    ..Although various strategies are available to manage nonresponders to an initial treatment for depression, no controlled trials address the utility of switching from an antidepressant medication to psychotherapy or vice versa...
  21. ncbi request reprint Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination
    Philip T Ninan
    Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30329, USA
    J Clin Psychiatry 63:434-41. 2002
    ....
  22. ncbi request reprint Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, PA 15213 2593, USA
    J Clin Psychiatry 63:493-500. 2002
    ..As nefazodone-mediated blockade of serotonin-2 receptors may directly relieve insomnia associated with depression, we examined the more specific effects of CBASP and nefazodone, singly and in combination, on sleep disturbances...
  23. ncbi request reprint Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination
    John Zajecka
    Department of Psychiatry, Rush Presbyterian St Luke s Medical Center, 1725 W Harrison Street, Suite 955, Chicago, IL 60612, USA
    J Clin Psychiatry 63:709-16. 2002
    ..This study compares the effects of antidepressant medication, psychotherapy, and combined treatment on sexual interest/satisfaction and function in patients with chronic major depression...
  24. ncbi request reprint Chronic depression and comorbid personality disorders: response to sertraline versus imipramine
    James M Russell
    Department of Psychiatry and Behavioral Sciences, The University of Texas Medical Branch at Galveston, 77555, USA
    J Clin Psychiatry 64:554-61. 2003
    ..Few studies, though, have systematically examined the clinical correlates of Axis II personality disorder comorbidity or its effect on treatment response or time to response...
  25. ncbi request reprint Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724 5002, USA
    Biol Psychiatry 54:806-17. 2003
    ..This randomized, placebo-controlled study of the efficacy and safety of nefazodone in preventing recurrence was conducted for patients with chronic MDD...
  26. ncbi request reprint Gender differences in depression and response to antidepressant treatment
    Diane M E Sloan
    Clinical Services Department, CardinalHealth, Inc, 218 Colwyn Terrace, West Chester, PA 19380, USA
    Psychiatr Clin North Am 26:581-94. 2003
    ....
  27. ncbi request reprint A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction
    Anita H Clayton
    University of Virginia, Charlottesville, VA 22903, USA
    J Clin Psychiatry 65:62-7. 2004
    ..Exploratory analyses of the association of testosterone and sexual functioning in women in the study were also performed...
  28. ncbi request reprint Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 30:405-16. 2005
    ..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...
  29. ncbi request reprint Mental symptoms and disorders during pregnancy
    Uriel Halbreich
    Biobehavioral Research Program, State University of New York at Buffalo, Buffalo, New York, USA
    CNS Spectr 9:176. 2004
  30. ncbi request reprint Chronic depression in women
    Susan G Kornstein
    Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298 0710, USA
    J Clin Psychiatry 63:602-9. 2002
    ..Young women should be screened carefully and treated vigorously to prevent the serious consequences of this condition...
  31. ncbi request reprint Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10021, USA
    Psychopharmacol Bull 37:73-87. 2003
    ..COMB was associated with less symptom re-emergence during the continuation phase than either monotherapy, particularly for partial remitters...
  32. ncbi request reprint Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O Hara St, Pittsburgh, PA 15213, USA
    Arch Gen Psychiatry 59:233-9. 2002
    ..Although various strategies have been proposed to treat antidepressant nonresponders, little controlled research has been published that examines prospectively the use of switching to an alternate antidepressant...
  33. doi request reprint Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool
    Gene V Wallenstein
    QualityMetric Incorporated, Lincoln, Rhode Island 02865, USA
    J Womens Health (Larchmt) 17:439-50. 2008
    ..To develop and validate the Premenstrual Symptoms Impact Survey (PMSIS), a brief web-based instrument for evaluating the impact of premenstrual symptoms on health-related quality of life (HRQOL)...
  34. ncbi request reprint Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination
    Robert M A Hirschfeld
    Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, Texas 77555 0188, USA
    Biol Psychiatry 51:123-33. 2002
    ..This study compared efficacy of nefazodone, psychotherapy, and their combination in improving psychosocial functioning in chronically depressed outpatients...

Research Grants4

  1. Symptom Onset Antidepressant Treatment for PMDD
    Susan Kornstein; Fiscal Year: 2009
    ..The findings of this study, designed to reflect real-life implementation (i.e., symptom onset), will assist in developing practical treatment guidelines for women with PMDD. ..
  2. Symptom Onset Antidepressant Treatment for PMDD
    Susan Kornstein; Fiscal Year: 2007
    ..The findings of this study, designed to reflect real-life implementation (i.e., symptom onset), will assist in developing practical treatment guidelines for women with PMDD. ..
  3. Symptom Onset Antidepressant Treatment for PMDD
    Susan G Kornstein; Fiscal Year: 2010
    ..The findings of this study, designed to reflect real-life implementation (i.e., symptom onset), will assist in developing practical treatment guidelines for women with PMDD. ..